MAP 2019 -  Molecular Analysis for Personalised Therapy is a unique meeting established by global opinion leaders. The congress aims to integrate insights from tumour sample analysis into daily practice.

The MAP Congress has grown into an influential, highly interactive forum which is a natural choice for specialists working in precision medicine in oncology.  The Congress programme is based on the genomic information obtained through the sequencing of all tumours and the tumour environment.

Organised by Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, the MAP Congress is the result of an enduring collaborative effort and offers its delegates the very latest thinking in the field.